A. Schulman Reports Fiscal 2017 Third-Quarter Results

- Strong performance in Asia-Pacific, Latin America and Engineered Composites offset by continued consolidation efforts in the United States and Canada region and a temporary hesitation of sales in Europe - On GAAP basis, earnings per diluted share were $0.47 compared with $0.53 in fiscal 2016 third quarter; adjusted earnings per diluted share were $0.63 compared with $0.79 in fiscal 2016 third quarter; - Fiscal 2017 third quarter adjusted earnings per diluted share of $0.63 includes the negative effect of foreign currency of $0.04 compared with last year; - Reported sales were $645.8 million; excluding the negative impact of foreign currency, sales rose 1.8 percent over the prior year period.

June 28, 2017 4:05 PM EDT

AKRON, Ohio, June 28, 2017 /PRNewswire/ -- A. Schulman, Inc. (Nasdaq: SHLM) today announced earnings for the quarter ended May 31, 2017 of $0.47 per diluted share, compared with $0.53 per diluted share in the prior year period. On an adjusted basis, reported earnings per share were $0.63 in the third quarter of fiscal 2017, compared with $0.79 in the third quarter of fiscal 2016. The fiscal 2017 third quarter adjusted earnings per diluted share of $0.63 includes the negative effect of foreign currency of $0.04 over the prior year period.

Joseph M. Gingo, chairman, president and chief executive officer stated, "I am very pleased with our strong performance in Asia-Pacific, Latin America and Engineered Composites. Our consolidated results were largely influenced by two factors. In our U.S and Canada region, while operations improved, our sales and profitability are still hampered by the complexity of the business consolidation in Evansville, Indiana. In Europe, a significant mid-quarter drop in polyolefin raw material prices interrupted our sales cycle and adversely impacted profitability. We have seen our sales cycle normalize in May and continue into June."

Consolidated net sales for the fiscal 2017 third quarter were $645.8 million, compared with $650.4 million in the same prior-year quarter. Excluding the negative impact of foreign currency translation in the third quarter of fiscal 2017 of $16.3 million, net sales rose 1.8 percent from a year ago.

GAAP operating income in the third quarter of fiscal 2017 was $32.2 million, compared with $31.6 million in the prior year period. Adjusted operating income margin was 5.7 percent in the third quarter of fiscal 2017, compared with 7 percent in the third quarter of fiscal 2016. On a year-to-date basis, the adjusted operating margin was 5.5 percent compared with 5.9 percent in the prior year.

Net income in the fiscal 2017 third quarter was $13.9 million, compared with $15.5 million in the year-ago period. On an adjusted basis, net income for the third quarter of fiscal 2017 was $18.5 million, compared with $25.2 million in the prior year period. Fiscal 2017 third-quarter adjusted EBITDA was $56 million, compared with $66.9 million in the third quarter of fiscal 2016. 

Cash Flow/Debt ReductionCash provided from operations was $73.6 million in the nine months ended May 31, 2017. During the quarter, the Company reduced its net debt position by $20.3 million to a balance of $880.4 million as of May 31, 2017. Net leverage at the end of the third quarter of fiscal 2017 was 4.13x.

Business Update and OutlookGingo stated, "Currency translation, although improving, is a continuing headwind. If the dollar stays at the end-of-May level for the duration of the fourth quarter this would further impact the Company's earnings by as much as two cents in the quarter and would result in 12 cents for currency impact compared with the Company's guidance for the full fiscal year.  

"With the return to a more normal sales pattern in Europe and strong performances in Latin America, Asia-Pacific and Engineered Composites, we foresee stronger year-over-year performance in our fiscal 2017 fourth quarter as we anticipate operational improvement in the U.S. and Canada region. Therefore, excluding the potential 2017 currency translation as noted above, we are maintaining our initial fiscal 2017 guidance of $2.5 billion to $2.6 billion in sales, adjusted EBITDA of $225 million to $230 million, adjusted earnings per diluted share in the range of $2.08 to $2.18 on an operating basis. Likewise, we continue to expect to achieve a return on invested capital of 11 percent to 12.5 percent in fiscal 2017.

"The trends that are starting to take shape in the fourth quarter are encouraging and will create added momentum as we progress into fiscal 2018," he said.

Please refer to the reconciliation of GAAP and Non-GAAP financial measures for the types of items excluded from the Company's business outlook.

Conference Call on the WebA live Internet broadcast of A. Schulman's conference call regarding fiscal 2017 third-quarter earnings can be accessed at 10:00 a.m. Eastern Time on June 29, 2017, on the Company's website, www.aschulman.com. An archived replay of the call will also be available on the website.

Investor Presentation MaterialsSenior executives of the Company may participate in meetings with analysts and investors throughout the fiscal year. The Company has posted presentation materials, portions of which may be used during such meetings, in the Investors section of its website at www.aschulman.com. The presentation will remain on the website as long as it is in use.

About A. Schulman, Inc. A. Schulman, Inc. is a leading international supplier of high-performance plastic compounds and resins headquartered in Akron, Ohio. Since 1928, the Company has been providing innovative solutions to meet its customers' demanding requirements. The Company's customers span a wide range of markets such as packaging, mobility, building & construction, electronics & electrical, agriculture, personal care & hygiene, sports, leisure & home, custom services and others. The Company employs approximately 4,900 people and has 53 manufacturing facilities globally. A. Schulman reported net sales of approximately $2.5 billion for the fiscal year ended August 31, 2016. Additional information about A. Schulman can be found at www.aschulman.com.

Use of Non-GAAP Financial MeasuresThis release includes certain financial information determined by methods other than in accordance with accounting principles generally accepted in the United States ("GAAP"). These non-GAAP financial measures include segment gross profit, SG&A expenses excluding certain items, segment operating income, operating income before certain items, net income excluding certain items, net income per diluted share excluding certain items and adjusted EBITDA, as discussed further in the Reconciliation of GAAP and Non-GAAP Financial Measures below. These non-GAAP financial measures are considered relevant to aid analysis and understanding of the Company's results and business trends. However, non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures, and tables included in this release reconcile each non-GAAP financial measure with the most directly comparable GAAP financial measure. The most directly comparable GAAP financial measures for these purposes are gross profit, SG&A expenses, operating income, net income and net income per diluted share. The Company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures, and should be read only in conjunction with the Company's consolidated financial statements prepared in accordance with GAAP.

While the Company believes that these non-GAAP financial measures provide useful supplemental information to investors, there are very significant limitations associated with their use. These non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures.

Cautionary Statements A number of the matters discussed in this document that are not historical or current facts deal with potential future circumstances and developments and may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historic or current facts and relate to future events and expectations. Forward-looking statements contain such words as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which management is unable to predict or control, that may cause actual results, performance or achievements to differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements, and that could adversely affect the Company's future financial performance, include, but are not limited to, the following:

  • worldwide and regional economic, business and political conditions, including continuing economic uncertainties in some or all of the Company's major product markets or countries where the Company has operations;
  • the effectiveness of the Company's efforts to improve operating margins through sales growth, price increases, productivity gains, and improved purchasing techniques;
  • competitive factors, including intense price competition;
  • fluctuations in the value of currencies in areas where the Company operates;
  • volatility of prices and availability of the supply of energy and raw materials that are critical to the manufacture of the Company's products, particularly plastic resins derived from oil and natural gas;
  • changes in customer demand and requirements;
  • effectiveness of the Company to achieve the level of cost savings, productivity improvements, growth and other benefits anticipated from acquisitions and the integration thereof, joint ventures and restructuring initiatives;
  • escalation in the cost of providing employee health care;
  • uncertainties regarding the resolution of pending and future litigation and other claims;
  • the performance of the global automotive market as well as other markets served;
  • further adverse changes in economic or industry conditions, including global supply and demand conditions and prices for products;
  • operating problems with our information systems as a result of system security failures such as viruses, cyber-attacks or other causes;
  • our current debt position could adversely affect our financial health and prevent us from fulfilling our financial obligations; and
  • failure of counterparties to perform under the terms and conditions of contractual arrangements, including suppliers, customers, buyers and sellers of a business and other third parties with which the Company contracts.

The risks and uncertainties identified above are not the only risks the Company faces. Additional risk factors that could affect the Company's performance are set forth in the Company's Annual Report on Form 10-K for the fiscal year ended August 31, 2016. In addition, risks and uncertainties not presently known to the Company or that it believes to be immaterial also may adversely affect the Company. Should any known or unknown risks or uncertainties develop into actual events, or underlying assumptions prove inaccurate, these developments could have material adverse effects on the Company's business, financial condition and results of operations.

SHLM_ALL

 

 

A. SCHULMAN, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three months ended May 31,

Nine months ended May 31,

2017

2016

2017

2016

(In thousands, except per share data)

Net sales

$

645,795

$

650,439

$

1,814,473

$

1,891,419

Cost of sales

547,368

540,965

1,525,845

1,587,192

Selling, general and administrative expenses

65,266

73,641

203,608

222,482

Restructuring expense

939

4,245

12,361

8,005

Operating income (loss)

32,222

31,588

72,659

73,740

Interest expense

13,179

13,557

39,450

40,965

Foreign currency transaction (gains) losses

(68)

392

1,575

2,071

Other (income) expense, net

(682)

(311)

(1,138)

(529)

Income (loss) before taxes

19,793

17,950

32,772

31,233

Provision (benefit) for U.S. and foreign income taxes

3,695

312

8,157

4,076

Net income (loss)

16,098

17,638

24,615

27,157

Noncontrolling interests

(320)

(241)

(868)

(1,075)

Net income (loss) attributable to A. Schulman, Inc.

15,778

17,397

23,747

26,082

Convertible special stock dividends

1,875

1,875

5,625

5,625

Net income (loss) available to A. Schulman, Inc. common stockholders

$

13,903

$

15,522

$

18,122

$

20,457

Weighted-average number of shares outstanding:

Basic

29,421

29,339

29,392

29,284

Diluted

29,530

29,474

29,496

29,459

Net income (loss) per common share available to A. Schulman, Inc. common stockholders

Basic

$

0.47

$

0.53

$

0.62

$

0.70

Diluted

$

0.47

$

0.53

$

0.61

$

0.69

Cash dividends per common share

$

0.205

$

0.205

$

0.615

$

0.615

Cash dividends per share of convertible special stock

$

15.00

$

15.00

$

45.00

$

45.00

 

 

A. SCHULMAN, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

May 31, 2017

August 31, 2016

(In thousands)

ASSETS

Current assets:

Cash and cash equivalents

$

50,130

$

35,260

Restricted cash

1,068

8,143

Accounts receivable, less allowance for doubtful accounts of $10,415 at May 31, 2017 and $11,341 at August 31, 2016

411,004

376,786

Inventories

297,104

263,617

Prepaid expenses and other current assets

38,783

40,263

Assets held for sale

6,586

Total current assets

804,675

724,069

Property, plant and equipment, at cost:

Land and improvements

31,218

32,957

Buildings and leasehold improvements

177,468

184,291

Machinery and equipment

450,250

447,932

Furniture and fixtures

34,361

34,457

Construction in progress

28,674

20,431

Gross property, plant and equipment

721,971

720,068

Accumulated depreciation

425,486

405,246

Net property, plant and equipment

296,485

314,822

Deferred charges and other noncurrent assets

87,141

88,161

Goodwill

260,768

257,773

Intangible assets, net

338,304

362,614

Total assets

$

1,787,373

$

1,747,439

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable

$

339,566

$

280,060

U.S. and foreign income taxes payable

3,783

8,985

Accrued payroll, taxes and related benefits

44,458

47,569

Other accrued liabilities

69,661

67,704

Short-term debt

21,453

25,447

Total current liabilities

478,921

429,765

Long-term debt

910,132

919,349

Pension plans

147,017

145,108

Deferred income taxes

49,873

59,013

Other long-term liabilities

24,270

25,844

Total liabilities

1,610,213

1,579,079

Commitments and contingencies

Stockholders' equity:

Convertible special stock, no par value

120,289

120,289

Common stock, $1 par value, authorized - 75,000 shares, issued - 48,529 shares at May 31, 2017 and 48,510 shares at August 31, 2016

48,529

48,510

Additional paid-in capital

277,867

275,115

Accumulated other comprehensive income (loss)

(115,501)

(120,721)

Retained earnings

219,032

219,039

Treasury stock, at cost, 19,064 shares at May 31, 2017 and 19,069 shares at August 31, 2016

(382,871)

(382,963)

Total A. Schulman, Inc.'s stockholders' equity

167,345

159,269

Noncontrolling interests

9,815

9,091

Total equity

177,160

168,360

Total liabilities and equity

$

1,787,373

$

1,747,439

 

 

A. SCHULMAN, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Nine months ended May 31,

2017

2016

(In thousands)

Operating activities:

Net income

$

24,615

$

27,157

Adjustments to reconcile net income to net cash provided from (used in) operating activities:

Depreciation

32,455

37,347

Amortization

26,381

30,163

Deferred tax provision (benefit)

(9,539)

(2,395)

Pension, postretirement benefits and other compensation

5,302

3,161

Changes in assets and liabilities, net of acquisitions:

Accounts receivable

(32,841)

2,574

Inventories

(32,694)

19,900

Accounts payable

64,795

(8,145)

Income taxes

(5,122)

(9,955)

Accrued payroll and other accrued liabilities

(1,131)

2,583

Other assets and long-term liabilities

1,345

(6,718)

Net cash provided from (used in) operating activities

73,566

95,672

Investing activities

Expenditures for property, plant and equipment

(30,719)

(34,618)

Proceeds from the sale of assets

2,750

1,184

Other investing activities

125

Net cash provided from (used in) investing activities

(27,844)

(33,434)

Financing activities:

Cash dividends paid to special stockholders

(5,625)

(5,625)

Cash dividends paid to common stockholders

(18,129)

(18,012)

Increase (decrease) in short-term debt

(2,283)

2,780

Borrowings on revolving credit facility

283,943

124,671

Repayments of revolving credit facility

(228,973)

(112,470)

Repayments of other long-term debt and capital leases

(66,735)

(97,978)

Noncontrolling interests' distributions

(53)

Issuances of stock, common and treasury

143

213

Redemptions of common stock

(711)

(1,077)

Purchases of treasury stock

Net cash provided from (used in) financing activities

(38,423)

(107,498)

Effect of exchange rate changes on cash

496

(2,186)

Net increase (decrease) in cash, cash equivalents, and restricted cash

7,795

(47,446)

Cash, cash equivalents, and restricted cash at beginning of period

43,403

96,872

Cash, cash equivalents, and restricted cash at end of period

$

51,198

$

49,426

Cash and cash equivalents

$

50,130

$

47,019

Restricted cash

1,068

2,407

Total cash, cash equivalents, and restricted cash

$

51,198

$

49,426

 

 

A. SCHULMAN, INC.

Reconciliation of GAAP and Non-GAAP Financial Measures

Unaudited

Three months ended May 31, 2017

Cost of Sales

GrossMargin

SG&A

Restructuring Expense

OperatingIncome

NonOperating (Income)Expense

Income Tax Expense (Benefit)

Net Income Available toASI CommonStockholders

DilutedEPS

(In thousands, except for %'s and per share data)

As reported

$

547,368

15.2

%

$

65,266

$

939

$

32,222

$

12,429

$

3,695

$

13,903

$

0.47

Certain items:

Accelerated depreciation (1)

(236)

(1)

237

49

188

0.01

Restructuring and related costs (3)

(1,993)

(939)

2,932

604

2,328

0.07

Lucent costs (4)

(104)

(1,626)

1,730

356

1,374

0.05

Tax (benefits) charges (7)

(890)

890

0.03

Gain on asset sale (10)

169

(35)

(134)

Total certain items

(340)

0.1

%

(3,620)

(939)

4,899

169

84

4,646

0.16

As Adjusted

$

547,028

15.3

%

$

61,646

$

$

37,121

$

12,598

$

3,779

$

18,549

$

0.63

Percentage of Revenue

9.5

%

5.7

%

2.9

%

Effective Tax Rate

15.4

%

Three months ended May 31, 2016

Cost of Sales

GrossMargin

SG&A

RestructuringExpense

OperatingIncome

Non Operating(Income)Expense

Income Tax Expense(Benefit)

Net IncomeAvailable to ASI Common Stockholders

DilutedEPS

(In thousands, except for %'s and per share data)

As reported

$

540,965

16.8

%

$

73,641

$

4,245

$

31,588

$

13,638

$

312

$

15,522

$

0.53

Convertible special stock dividends (9)

1,875

0.03

Certain items:

Accelerated depreciation (1)

(1,283)

(3)

1,286

243

1,043

0.03

Costs related to acquisitions and integrations (2)

(423)

(1,020)

1,443

235

1,208

0.04

Restructuring and related costs (3)

(1,647)

(3,628)

(4,245)

9,520

(127)

2,099

7,548

0.23

Lucent costs (4)

(466)

(1,485)

1,951

385

1,566

0.05

Accelerated amortization of debt issuance costs (6)

(163)

34

129

Tax (benefits) charges (7)

3,664

(3,664)

(0.12)

Total certain items

(3,819)

0.6

%

(6,136)

(4,245)

14,200

(290)

6,660

9,705

0.26

As Adjusted

$

537,146

17.4

%

$

67,505

$

$

45,788

$

13,348

$

6,972

$

25,227

$

0.79

Percentage of Revenue

10.4

%

7.0

%

3.9

%

Effective Tax Rate

21.5

%

 

 

Nine months ended May 31, 2017

Cost of Sales

Gross Margin

SG&A

RestructuringExpense

Operating Income

NonOperating (Income)Expense

IncomeTax Expense(Benefit)

Net IncomeAvailable to ASI Common Stockholders

DilutedEPS

(In thousands, except for %'s and per share data)

As reported

$

1,525,845

15.9

%

$

203,608

$

12,361

$

72,659

$

39,887

$

8,157

$

18,122

$

0.61

Certain items:

Asset impairment (8)

(678)

678

(1,623)

474

1,827

0.06

Accelerated depreciation (1)

(1,059)

(1)

1,060

218

842

0.03

Costs related to acquisitions and integrations (2)

(57)

(548)

605

125

480

0.02

Restructuring and related costs (3)

(1,042)

(7,773)

(12,361)

21,176

4,362

16,814

0.56

Lucent costs (4)

(190)

(2,945)

3,135

646

2,489

0.08

CEO transition costs (5)

(196)

196

40

156

0.01

Accelerated amortization of debt issuance costs (6)

(227)

47

180

0.01

Tax (benefits) charges (7)

(1,428)

1,428

0.05

Gain on asset sale (10)

169

(35)

(134)

Total certain items

(2,348)

0.1

%

(12,141)

(12,361)

26,850

(1,681)

4,449

24,082

0.82

As Adjusted

$

1,523,497

16.0

%

$

191,467

$

$

99,509

$

38,206

$

12,606

$

42,204

$

1.43

Percentage of Revenue

10.6

%

5.5

%

2.3

%

Effective Tax Rate

20.6

%

Nine months ended May 31, 2016

Cost of Sales

Gross Margin

SG&A

RestructuringExpense

OperatingIncome

Non Operating (Income)Expense

Income TaxExpense(Benefit)

Net IncomeAvailable toASI Common Stockholders

Diluted EPS

(In thousands, except for %'s and per share data)

As reported

$

1,587,192

16.1

%

$

222,482

$

8,005

$

73,740

$

42,507

$

4,076

$

20,457

$

0.69

Certain items:

Accelerated depreciation (1)

(4,779)

(17)

4,796

1,127

3,669

0.12

Costs related to acquisitions and integrations (2)

(2,522)

(5,048)

7,570

1,779

5,791

0.19

Restructuring and related costs (3)

(2,532)

(9,422)

(8,005)

19,959

(488)

4,872

15,575

0.54

Lucent costs (4)

(1,844)

(4,424)

6,268

1,473

4,795

0.17

Accelerated amortization of debt issuance costs (6)

(437)

103

334

0.01

Tax (benefits) charges (7)

3,197

(3,197)

(0.11)

Total certain items

(11,677)

0.6

%

(18,911)

(8,005)

38,593

(925)

12,551

26,967

0.92

As Adjusted

$

1,575,515

16.7

%

$

203,571

$

$

112,333

$

41,582

$

16,627

$

47,424

$

1.61

Percentage of Revenue

10.8

%

5.9

%

2.5

%

Effective Tax Rate

23.5

%

 

1 - Accelerated depreciation is related to restructuring plans in the Company's USCAN and EMEA segments.

2 - Costs related to acquisitions and integrations primarily include third party professional, legal, IT and other expenses associated with successful and unsuccessful full or partial acquisition and divestiture/dissolution transactions, as well as certain employee-related expenses such as travel, one-time bonuses and post-acquisition severance separate from a formal restructuring plan.

3 - Restructuring and related costs include items such as employee severance charges, lease termination charges, curtailment gains/losses, other employee termination costs and charges related to the reorganization of the legal entity structure. Refer to Note 12 in the Company's Quarterly Report on Form 10-Q for further discussion.

4 - Lucent costs primarily represent legal and investigation costs related to resolving the Lucent matter, product manufacturing costs for reworking existing Lucent inventory, obsolete Lucent inventory reserve costs, and dedicated internal personnel costs that would have otherwise been focused on normal operations.

5 - CEO transition costs represent charges for deferred compensation granted to Bernard Rzepka.

6 - Write off of debt issuance costs are related to prepayments of $56.0 million of Term Loan B. Refer to Note 3 in the Company's Quarterly Report on Form 10-Q for further discussion.

7 - Tax (benefits) charges represent the Company's quarterly non-GAAP tax based on the overall estimated annual non-GAAP effective tax rates.

8 - Asset impairment relates to the discontinuation of information technology assets in the USCAN segment and future cash settlement of a commitment to a local government.

9 - Convertible special stock dividends have been added back as the 2.4 million shares of convertible special stock were considered dilutive to the third quarter of fiscal 2016.

10 - Gain related to sale of assets that had previously been classified as held for sale.

 

 

A. SCHULMAN, INC.

ADJUSTED EBITDA RECONCILIATION

(Unaudited)

Three months ended May 31,

Nine months ended May 31,

2017

2016

2017

2016

(In thousands)

Net income available to A. Schulman, Inc. common stockholders

$

13,903

$

15,522

$

18,122

$

20,457

     Interest expense

13,179

13,557

39,450

40,965

     Provision for U.S. and foreign income taxes

3,695

312

8,157

4,076

     Depreciation and amortization

18,977

22,409

58,836

67,510

     Noncontrolling interests

320

241

868

1,075

     Convertible special stock dividends

1,875

1,875

5,625

5,625

     Other (1)

(750)

163

437

1,825

EBITDA, as calculated

$

51,199

$

54,079

$

131,495

$

141,533

     Non-GAAP Adjustments (2)

4,765

12,832

25,790

33,501

EBITDA, as adjusted

$

55,964

$

66,911

$

157,285

$

175,034

 

(1) - Other includes Foreign currency transaction (gains) losses and Other (income) expense, net.

(2) - For details on Non-GAAP adjustments, refer to "Reconciliation of GAAP and Non-GAAP Financial Measures", items (2) - (8).  Amounts are included in Operating Income. Accelerated depreciation on the "Reconciliation of GAAP and Non-GAAP Financial Measures" has been excluded as it is already included in Depreciation and amortization above. The three months ended May 31, 2017 exclude additional depreciation expense which is in restructuring and related costs as it has already been included in Depreciation and amortization above. The nine months ended May 31, 2016 also include additional amortization expense which is in SG&A in the "Reconciliation of GAAP and Non-GAAP Financial Measures". This expense has been added back to adjusted EBITDA.

 

 

A. SCHULMAN, INC.

SUPPLEMENTAL SEGMENT INFORMATION

(Unaudited)

Net Sales

Net Sales

Three months ended May 31,

Nine months ended May 31,

EMEA

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

Custom Concentrates and Services

$

174,394

$

177,863

$

(3,469)

(2.0)

%

$

481,512

$

506,773

$

(25,261)

(5.0)

%

Performance Materials

143,632

144,505

(873)

(0.6)

%

409,488

434,021

(24,533)

(5.7)

%

Total EMEA

$

318,026

$

322,368

$

(4,342)

(1.3)

%

$

891,000

$

940,794

$

(49,794)

(5.3)

%

Net Sales

Net Sales

Three months ended May 31,

Nine months ended May 31,

USCAN

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

Custom Concentrates and Services

$

65,613

$

66,841

$

(1,228)

(1.8)

%

$

188,496

$

194,153

$

(5,657)

(2.9)

%

Performance Materials

102,268

116,497

(14,229)

(12.2)

%

287,721

338,284

(50,563)

(14.9)

%

Total USCAN

$

167,881

$

183,338

$

(15,457)

(8.4)

%

$

476,217

$

532,437

$

(56,220)

(10.6)

%

Net Sales

Net Sales

Three months ended May 31,

Nine months ended May 31,

LATAM

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

Custom Concentrates and Services

$

32,396

$

32,156

$

240

0.7

%

$

89,739

$

94,568

$

(4,829)

(5.1)

%

Performance Materials

15,012

11,221

3,791

33.8

%

39,547

32,170

7,377

22.9

%

Total LATAM

$

47,408

$

43,377

$

4,031

9.3

%

$

129,286

$

126,738

$

2,548

2.0

%

Net Sales

Net Sales

Three months ended May 31,

Nine months ended May 31,

APAC

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

Custom Concentrates and Services

$

24,514

$

23,531

$

983

4.2

%

$

72,677

$

69,191

$

3,486

5.0

%

Performance Materials

28,714

23,349

5,365

23.0

%

80,202

68,444

11,758

17.2

%

Total APAC

$

53,228

$

46,880

$

6,348

13.5

%

$

152,879

$

137,635

$

15,244

11.1

%

Net Sales

Net Sales

Three months ended May 31,

Nine months ended May 31,

Consolidated

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

Engineered Composites

$

59,252

$

54,476

$

4,776

8.8

%

$

165,091

$

153,815

$

11,276

7.3

%

Custom Concentrates and Services

296,917

300,391

(3,474)

(1.2)

%

832,424

864,685

(32,261)

(3.7)

%

Performance Materials

289,626

295,572

(5,946)

(2.0)

%

816,958

872,919

(55,961)

(6.4)

%

Total Consolidated

$

645,795

$

650,439

$

(4,644)

(0.7)

%

$

1,814,473

$

1,891,419

$

(76,946)

(4.1)

%

 

 

Segment Gross Profit

Segment Gross Profit

Three months ended May 31,

Nine months ended May 31,

2017

2016

$ Change

% Change

2017

2016

$ Change

% Change

(In thousands, except for %'s)

EMEA

$

42,509

$

49,852

$

(7,343)

(14.7)

%

$

126,297

$

136,489

$

(10,192)

(7.5)

%

USCAN

21,844

32,560

(10,716)

(32.9)

%

66,420

90,095

(23,675)

(26.3)

%

LATAM

9,928

9,055

873

9.6

%

28,940

27,226

1,714

6.3

%

APAC

9,155

8,080

1,075

13.3

%

27,189

24,153

3,036

12.6

%

EC

15,331

13,746

1,585

11.5

%

42,130

37,941

4,189

11.0

%

Total segment gross profit

$

98,767

$

113,293

$

(14,526)

(12.8)

%

$

290,976

$

315,904

$

(24,928)

(7.9)

%

Accelerated depreciation and restructuring related costs

(236)

(2,930)

2,694

(91.9)

%

(2,101)

(7,311)

5,210

(71.3)

%

Costs related to acquisitions and integrations

(423)

423

%

(57)

(2,522)

2,465

(97.7)

%

Lucent costs (1)

(104)

(466)

362

%

(190)

(1,844)

1,654

(89.7)

%

Total gross profit

$

98,427

$

109,474

$

(11,047)

(10.1)%

$

288,628

$

304,227

$

(15,599)

(5.1)

%

 

(1)Refer to Note 13, Commitments and Contingencies, for additional discussion on this matter. Lucent costs in cost of sales include additional product and manufacturing operational costs for reworking inventory.  Lucent costs in selling, general and administrative expenses include legal and investigative costs. In addition, in the three and nine months ended May 31, 2016, Lucent costs in SG&A also include dedicated internal personnel costs that would have otherwise been focused on normal operations.

(2)Retructuring related costs for the three and nine months ended May 31, 2017 of $2.0 million and $8.8 million, respectively, and for the three and nine months ended May 31, 2016 of $5.3 million and $12.0 million, respectively, primarily included in selling, general and administrative expenses in the Company's statements of operations, are costs associated with professional fees for outside strategic consultants regarding actions to improve the profitability of the organization and efficiency of its operations, and costs associated with reorganizations of the legal entity structure of the Company.  Restructuring expenses included in restructuring expense in the Company's statement of operations include costs permitted under ASC 420, Exit or Disposal Obligations, such as severance costs, outplacement services and contract termination costs.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/a-schulman-reports-fiscal-2017-third-quarter-results-300481451.html

SOURCE A. Schulman, Inc.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Raising Prices, Dividend, Earnings, Definitive Agreement